Parallax Volatility Advisers, L.P. Cytokinetics Inc Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 50,300 shares of CYTK stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,300
Previous 38,460
30.79%
Holding current value
$2.09 Million
Previous $2.03 Million
16.55%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.24MPut Options Held
2.14M-
Black Rock Inc. New York, NY14.7MShares$611 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$496 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$448 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$328 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$257 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.92B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...